Tess A. O'Meara, Julia Quintanilha, Paolo Tarantino, Daniel Abravanel, Ryon P. Graf, Eliezer Mendel Van Allen, Nancy U. Lin, Sara M. Tolaney. "Genomic alterations (GAs) associated with durability of benefit from trastuzumab deruxtecan (T-DXd), trastuzumab emtansine (T-DM1) and sacituzumab govitecan (SG) in metastatic breast cancer (MBC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.1048